9:00 - Opening remarks: Colette Marshall, Chief Executive, Diabetes UK 

9:10 - Opening Plenary Lecture: Bridging the inequalities in cardiometabolic care: From evidence to action

Professor Kamlesh Khunti, Professor of Primary Care Diabetes and Vascular Medicine, University of Leicester 

We are honoured to welcome Professor Kamlesh Khunti, one of the world’s leading voices in diabetes research, care delivery, and health policy.  Drawing on expertise that spans primary care, population health, and system-wide improvement, Professor Khunti will set the tone for the conference with a broad, forward-looking vision for the future of diabetes care. 

His plenary lecture will examine where inequities in diabetes care persist, and why acknowledging their existence is essential if we are to close the gaps.  He will highlight the collective responsibility of our professional communities to design services that leave no one behind, and to align our efforts with national priorities such as the Fit for the Future: 10-Year Health Plan for England. 

This opening session will establish the “why and how to overcome” that underpins the next three days, preparing delegates for deeper discussion across the full spectrum of diabetes science, clinical practice, and innovation.

09.50 - Data is power: How national intelligence can drive equity and quality in diabetes care

Dr Marc Atkin, National Specialty Advisor for Diabetes, NHS England & Dr Clare Hambling, National Clinical Director for Diabetes and Obesity, NHS England

Following the opening address from Diabetes UK and the opening plenary setting out our collective ambition to tackle diabetes health inequity, this centre-stage session brings together national leadership from NHS England to explore how data and intelligence can drive meaningful improvement in diabetes (and obesity) care.

Dr Clare Hambling and Dr Marc Atkins will share an open national update on key developments in the data landscape: highlighting emerging priorities, new opportunities, and how national intelligence can better support quality improvement, reduce unwarranted variation, and strengthen equity across systems.

The session will reflect on how established frameworks and datasets can be used more purposefully in today’s policy and financial climate, shifting the focus from data collection to insight, action and impact.

This session will also signpost to related symposia, workshops and professional interest network sessions across the next three days, helping delegates navigate where deeper dives into data, quality improvement, inequalities and service transformation will continue throughout the conference.

A practical session for UK and Irish healthcare professionals on the Insulin detemir discontinuation. The session will review what guidance exists, give tips and example case studies for implementing the change. Sanofi products will be discussed at this promotional symposium.

This is a promotional talk for UK and Irish healthcare professionals only.

MAT-XU-2600636 (v1.0) | March 2026

Unlock the full potential of Continuous Glucose Management technology by moving beyond real-time data to proactive glucose management. This session explores how predictive features can anticipate hypoglycaemia before it occurs. Helping translate complex data into actionable insights, this session aims to help attendees master the power of prediction.

Session title: Spotting and escalating foot infections in primary care

Short presentations regarding spotting, and escalating foot infections in primary care followed by roundtable discussions.

Triage and management of emergency foot infection in community the DFEET Project 

Vanessa Golding, National Strategic Lead for Diabetes footcare 

Foot screening complexities in Primary Care 

Reena Patel, Practice Nurse, Spinney Hill Medical Centre, Leicester

ACT NOW foot triage update

Jayne Robbie, Specialist Podiatrist, University Hospitals Birmingham NHS Trust

Roundtable discussions 

Facilitator:  Joelle Baynham, Consultant Podiatrist - Diabetes Inpatients, University Hospitals Dorset NHS Trust

Chair: Vanessa Golding, National Strategic Lead for Diabetes footcare

Themes: Overlooked complications, underserved topics

Oral health is one of the most overlooked components of diabetes care. Yet periodontal disease and diabetes exist in a harmful bi-directional relationship, each worsening the other and contributing to increased cardiovascular risk, impaired nutrition, and reduced quality of life.

These challenges are felt most acutely in disadvantaged communities, where access to dental services is limited, food insecurity is common, and inequalities in diabetes outcomes are already stark. For many people living with diabetes, poor oral health is not simply a dental issue, but a barrier to effective self-management, healthy eating, and overall wellbeing.

This session, led by the IDEAL Diabetes collaboration, will explore why oral health remains a missing piece in diabetes care pathways and how under-recognition contributes to avoidable harm. Using data on inequities in access to dental and nutritional services, alongside real-world patient journeys, the speakers will illustrate how oral health, diet, deprivation and diabetes complications intersect in everyday clinical practice.

Through perspectives from dentistry, diabetes care and lived experience, the session will highlight where current NHS pathways fail to join up, and how simple, team-based actions can begin to close these gaps.

11:30 - The current evidence base: understanding the intersection between oral health, diabetes inequity, and clinical outcomes.

Dr Zehra Yonel, Clinical Lecturer - Restorative Dentistry, University of Birmingham

11:40 - Where dental care fits within existing NHS diabetes pathways, and opportunities for better integration.

John Grumitt, Chair, IDEAL CIC & Ambassador, Diabetes UK & Person with type 1 diabetes lived experience

11:50 - A real-world lived experience of navigating NHS dental services at times of need while living with diabetes.

Dr Dominika Antoniszczak, Dentist with special interest in Periodontics and Diabetes & Founder, Periodontitis-Diabetes Hub & Person with type 1 diabetes lived experience

12:00 - Seeing the signs, facing the barriers and acting together.

Tara West, Dental Hygienist with specialist interest in diabetes and dental health

People living with diabetes who experience inequity in care are often those who face the greatest barriers to accessing healthcare. When engagement with services does occur, it may be brief or fragmented - meaning the window of opportunity to make a meaningful difference can be limited and must not be lost.

This places a responsibility on healthcare systems and professionals to ensure that every clinical encounter counts. “Getting it right first time” is not only about clinical decision-making, but about designing services, pathways, and environments that recognise disadvantage, reduce friction, and actively support engagement - particularly for those least able to navigate complex systems.

In this session, Prof Gerry Rayman, GIRFT Clinical Lead for Adult Diabetes Care, and Dr Fulya Mehta, National Speciality Advisor for Children and Young Adults, NHS England, will outline current and upcoming GIRFT diabetes initiatives across the life course. They will highlight how GIRFT’s work complements the strategic priorities of Diabetes UK and other national stakeholders, and how coordinated, system-level action can help level the quality of diabetes care - so that no opportunity for impact is missed, and no one is left behind.

11:30 - 11:50 - GIRFT Diabetes initiatives - adults

Professor Gerry Rayman, Consultant Diabetologist, Diabetes and Endocrine Centre, Ipswich Hospitals NHS Trust

11:50 - 12:10 - GIRFT Diabetes initatives - children & young adult

Dr Fulya Mehta, National Speciality Advisor for Children and Young Adults, NHS England

Modern therapies requiring collaboration between Ophthalmology and Diabetes

Talk 1 - Presentation by Dr Arya Ghatge - Frequency of Rapid Improvement in Glycaemic Control in Gloucestershire over a 5-year period and Effects on Diabetic Retinopathy

Talk 2 - Dr Garry Tan – proposal for suggested pathway for diabetic eye disease following commencement on GLP-1 agonists.

General discussion - chaired by Garry Tan and Peter Scanlon

Talk 4 - Presentation by Dr Arya Ghatje – Is it in our patient’s best interest to continue to screen patients over 80yrs with no retinopathy as they become increasingly frail?

General discussion - chaired by Garry Tan and Peter Scanlon

Introduction and setting the scene - Dr Alexandros Liarakos

The ACF route: what it offers, what it doesn’t, and what I wish I’d known - Dr Angelica Sharma

The non-ACF route: lessons and experiences - Dr Gordon Sloan

Developing independence in diabetes research: experiences and key career decisions - Dr Ahmed Iqbal

Panel discussion and audience Q&A 

Themes: Healthcare inequity

Specialisms: Community care and Specialist care

The symposium will open with two clinical case scenarios illustrating how unequal diabetes care plays out in real-world practice. There will be strong interaction between panel speakers and active engagement with delegates. The focus will be on solutions, framed around Diabetes UK’s latest strategy.

Themes: Youth, mental health

Specialisms: Specialist care and Primary Care

Integrating diabetes care into mental health settings, including managing high-risk cases.

13:25 - Introduction to mental health and high risk diabetes

Dr Christopher Garrett, Consultant in diabetes psychiatry, Bart's Health and East London Foundation Trust 

13:40 - Diabetes and Mental Health: Breaking the Cycle in Lothian

Catriona Howes, Consultant liaison psychiatrist, Western General Hospital in Edinburgh

13:50 - Recurrent DKA: using mental health law

Dr Fareed Oomer, ST6 Psychiatry trainee, Bart's Health and East London Foundation Trust 

14:00 - Recurrent DKA: should we try HCL for this? 

Dr Finola Cullenbrooke, ST6, Psychiatry, Bart's Health and East London Foundation Trust 

14:10 - 14:20 - A National DKA Prevention Pathway

Kirsty MacLennan, Consultant Clinical Psychologist

14:20 - 14:25 - Q&A

Themes: Diabetes & pregnancy

Specialisms: Clinical science and Specialist care

To summarise the latest research about optimal postnatal care in women with diabetes.

13.25 - 13.45 - Breastfeeding interventions in women with diabetes

Sarah Dib, Post-doctoral researcher, University of Leicester

13.45 - 14.05 - T2D and CVD after GDM: what are the risks?

Erica P Gunderson PhD, MPH, Professor, Department of Health and Systems Science, Kaiser Permanente Bernard J.Tyson School of Medicine

14.05 - 14.25 - Lifestyle interventions for prevention of future GDM and T2DM

Dr Abi Merriel, Senior Clinical Lecturer in Obstetrics and Honorary Consultant Obstetrician, University of Liverpool

Let’s rethink what’s possible in diabetes care. Join Dr Hood Thabit, Dr Myuri Moorthy and Lead Diabetes Specialist Nurse Katie Hards to explore how innovative teams are making Omnipod® 5 accessible to everyone. Scalable starts. Multidisciplinary teamwork. Inclusive access. Partnering for progress starts here.

INTERACTIVE

Themes: Tech, ethics

- Get ready to use your phones in this interactive exploration of AI in diabetes nutrition

- Practical demonstrations of AI tools currently available for dietitians and diabetes specialists

- Evaluate AI as a friend, foe, or the future of nutrition care through live examples

- Build confidence in safely integrating AI technology into everyday clinical practice

INTERACTIVE

Themes: Complications, foot, MDT systems of care

Specialisms: Community care, Specialist care, Primary care

Short specialist MDT presentations then interactive panel discussion of challenges in managing infection across the healthcare environment to incorporate primary secondary care and microbiology, diabetes and vascular surgery.

Talk 1 - Overview of infection challenge FD UK / Wounds UK consensus document 

Professor Mike Edmonds, Consultant Diabetologist

Talk 2 - Diabetes inpatients - challenges in acute care front door emergencies and triage 

Joelle Baynham, Consultant Podiatrist

Talk 3 - Sole searching: Navigating antibiotic choices in the face of resistance 

Harriet Launders, Anti-Infectives Pharmacist

Talk 4 - Multi-resistant infection management and OPAT

Coming soon

Panel discussion & Q&A

13:25 - 13:30

A New Local Pre-Operative Diabetes Optimisation Service

Chelsea Henshaw, Foundation Year 2 Doctor, Princess Royal University Hospital

13:31 - 13:36

Are inpatients with hypoglycaemia managed as per Trust and Joint British Diabetes Societies (JBDS) guidance at Aintree University Hospital?

Amirah Husna Binti Noor Azman, Foundation Year 2 Doctor, Aintree University Hospital, University Hospitals of Liverpool Group

13:37 - 13:42

Reducing insulin errors in elderly inpatients with staff education and optimising bedtime snacks.

Amal Puri

13:43 - 13:48

Improving Inpatient Diabetes Care in the Frail Adult : A QIP based on JBDS guidelines(2023)

Varghese Vilangupara Benny, ST4 Specialty registrar in Geriatric Medicine, Nevill Hall Hospital

13:49 - 13:54

Inpatient admissions as opportunities to promote sustainable and safer diabetes care: real-world patterns of insulin pen device use in hospitalised adults

Shreyans Darla, Internal Medicine Trainee/Academic Clinical Fellow, UHB NHS FT/Aston University

13:55 - 14:00

Improving falls prevention through targeted risk assessment and interventions at a tertiary healthcare centre

Annette Loudon, Nursing Manager, Dasman Diabetes Institute

14:01 - 14:06

PenSwitch: a campaign promoting reusable insulin pens for sustainable diabetes care

Bethany Draper, Medical Student, University of Exeter Medical School

14:07 - 14:12

Using Indices of Multiple Deprivation (IMD) to Ensure Equitable Rollout of Hybrid Closed Loop (HCL) Technology Across an Affluent AYA Cohort

Melanie Pritchard, Diabetes Specialist Nurse, University Hospitals Dorset

14:13 - 14:18

Improving Access and Efficiency: Group Education for Initiating GLP1 receptor agonists and GLP1/GIP receptor agonists Therapy

Jacqueline Mc McGillivray, Senior Diabetes Specialist Nurse, NHS Grampian

14:19 - 14:24

Scaling preparedness: using primary care networks to reach Black women with diabetes earlier

Anita Banerjee, ST7 in diabetes / Diabetes registrar, Mersey and West Lancashire teaching hospitals NHS trust

13:25 - 13:40

Transdifferentiation of delta- to beta-cells is increased during mouse pregnancy and is altered by hyperglycemia

David Hill, Senior Scientist, Lawson Research Institute

13:40 - 13:55

Ethinyl estradiol improves glucose homeostasis and modulates pancreatic and gut endocrine function in female ob/ob mice

Ananyaa Sridhar, Research Associate, Ulster University

13:55 - 14:10

Synthetic estrogen exposure alters endometrial responses in streptozotocin-induced diabetic mice

Dawood Khan, Lecturer, Ulster University

14:10 - 14:25

Soluble L-Selectin as an immune marker in type 1 diabetes

Kathleen Gillespie, Professor, University of Bristol

Everyone in the diabetes community benefits if early career researchers and clinicians are able to fulfil their potential. This session will support academics and clinicians to consider barriers and enablers of diabetes careers for diverse groups.

Talk 1 - Building a healthy research culture to support diverse talent

Liz Simmonds, Head of research culture, University of Cambridge

Talk 2 - Neurodiversity and diabetes careers: how can we do better? 

Almuth McDowall, Professor of Organisational Psychology, Birbeck University of London

Talk 3 - Supporting talented people from diverse ethnic groups: how can we do better? 

Bernadette Adeyileka-Tracz, CEO, Diabetes Africa

Discussion and Q&A

Chairs:

- Professor Angus Jones, University of Exeter and Honorary Consultant Physician, Royal Devon University Healthcare NHS Foundation Trust

- Professor Helen Murphy, Professor of Medicine, University of East Anglia

Thematic area: Health inequalities & equity 

Theme: Technology & innovation

Specialisms: Clinical science, Community care, Specialist care and Primary care

In this session, the chief investigators of the UK-based FreeDM2 randomised controlled trial will present the latest clinical outcomes on the use of continuous glucose monitoring (CGM) in people living with type 2 diabetes, building on insights from the landmark FLASH-UK study.

Speakers will focus on the core gluco-metabolic outcomes of FreeDM2, including HbA1c, CGM metrics, and therapy changes, and discuss their implications for future diabetes care strategy. The session will set the scene for the conference’s wider exploration of equity, opening discussion on how access to diabetes technologies might be more effectively levelled across both type 2 and type 1 diabetes populations.

14:35 - Introduction

Professor Pratik Choudhary, Professor in Diabetes, University of Leicester & Honorary Consultant in Diabetes, University Hospitals of Leicester NHS Trust (Chair)

14:40 - Study design, rationale and baseline data

Dr Lalantha Leelarathna, Clinical Associate Professor, Imperial College School of Medicine & Consultant in Diabetes, Imperial College Healthcare NHS Trust

14:50 - HbA1c (primary outcome) - CGM metrics and therapy changes

Dr Emma Wilmot, Associate Professor, University of Nottingham & Honorary Consultant Diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust

15:00 - Cost-effectiveness analysis

Professor Rachel Elliott, Professor in Health Economist, University of Manchester

15:10 - Discussion and Q&A

Chair: Professor Pratik Choudhary, Professor in Diabetes, University of Leicester & Honorary Consultant in Diabetes, University Hospitals of Leicester NHS Trust

This session will explore the evidence behind the use of low-carbohydrate diets for people living with type 2 diabetes, from research trials through to clinical practice. Alongside discussion of effectiveness and outcomes, this session will consider how these diets might practically be implemented and supported in routine NHS care. We will also share first-hand perspectives from practitioners delivering and supporting these interventions, offering insights into acceptability and translation into real-world delivery.

Speaker:

Dr Elizabeth Morris, GP & Clinical Lecturer, University of Oxford

15.00 - Q&A

This is a promotional sponsored symposium developed, organised, and funded by Lilly for UK Healthcare Professionals. Lilly products will be discussed. Lilly has provided a sponsorship towards this conference, however, have had no input, control, or influence over the agenda, speaker selections, presentations, or collateral content, except for this symposium session. Prescribing Information and Adverse Event reporting information will be available during the session.

CMAT-20107 April 2026

This spotlight session explores how automated insulin delivery services in England can navigate the evolving funding landscape. Anna Groom will share key lessons learned from the past two years, highlighting what has worked, what challenges services have faced, and how funding approaches continue to shift. Ideal for anyone looking to understand funding realities and prepare their service for future success.

The Integrated Career and Competency Framework for Adult Diabetes Nursing has shaped diabetes specialist nursing practice for over two decades. As diabetes technologies and automated insulin delivery systems become embedded in routine care, the framework has been expanded to support nurses across community, primary, secondary, and inpatient settings. This Professional Interest Network session will explore how early-career diabetes specialist nurses can use the updated framework to build confidence, competence, and career development in an evolving clinical landscape.

Key learning points / take-home messages

1. How the updated competency framework supports early-career diabetes specialist nurses in maintaining safe, confident, and contemporary practice.

2. Understanding the new diabetes technologies competency, including automated insulin delivery systems and their application across care settings.

3. Using the framework to support career progression, professional development, and workforce readiness.

4. Preparing the diabetes nursing community for the next phase of diabetes care and population need.

Themes: T1D Tech, inequality

This symposium will explore how diabetes technology can be delivered more equitably and effectively for people living with type 1 diabetes. Drawing on clinical and psychiatric expertise, speakers will discuss the subtleties of individualising pathways to closed-loop care.

The session will also examine real-world adoption of continuous glucose monitoring (CGM) and closed-loop technologies, including how clinicians assess safety and accuracy when people present with commercially available devices. It provides the context for a linked interactive workshop the following day (G5 – Confidence with diabetes technology: clinical safety and care pathways), where highly complex case examples will be explored to build confidence in safer, person-centred technology access.

16:15 - 16:30 - The importance of CGM choice and accuracy

Dr Emma Wilmot, Associate Professor and Honorary Consultant Diabetologist, University of Nottingham and University Hospitals of Derby and Burton

16:30 - 16:45 - Hybrid Closed Loop rollout - Current progress and future system challenges

Dr Alistair Lumb, Consultant in Diabetes, Oxford University Hospitals NHS Foundation Trust & Chair, Diabetes Technology Network-UK

16:45 - 17:00 - Mental health considerations in HCL

Dr Chris Garrett, Consultant in Diabetes Psychiatry, Barts Health NHS Trust & East London NHS Foundation Trust 

17:00 - 17:15 - Supporting HCL in high-risk situations

Dr Peter Jacob, Consultant in Diabetes & Endocrinology, Barts Health NHS Trust

Chair: Dr Alistair Lumb, Consultant in Diabetes, Oxford University Hospitals NHS Foundation Trust & Chair, Diabetes Technology Network-UK

Themes: Research & discovery

Highlighting three recent areas of cutting-edge world-leading diabetes breakthroughs from UK-based basic and clinical researchers. Includes basic and clinical obesity research as well as personalisation of glucose-lowering therapy.

16:15 - Obesity and overweight in type 1 diabetes: Impact of new technologies and drugs

Professor Helen Colhoun, AXA Chair of Medical Informatics and Life Course Epidemiology, University of Edinburgh 

16:35 - The hidden benefits of weight loss on fat tissues

Dr William Scott, Welcome Trust Clinical Research Career Development Fellow, Institute of Clincial Science, Imperial College London

16:55 - Advancing personalised treatment selection in type 2 diabetes: refinements to the Exeter 5-drug model

Pedro Cardoso, Postdoctoral Research Associate, Clinical and Biomedical Sciences, Royal Devon & Exeter Hospital, University of Exeter Medical School

16:15 - 16:45 - Diabetes UK Nursing and Allied Healthcare Professional Diabetes Research Award

Chairs:

Dr Reza Zaidi, Consultant, Royal Liverpool & Broadgreen University Hospitals NHS Trust

Juliette Palmer, Diabetes Specialist Nurse, Brownlow Health Liverpool

Speakers:

16:15 - 16:20

Service evaluation of an inner London acute NHS trust to determine whether there is equitable access to insulin pumps for people with T1DM

Eva Sheriene Casiechetty, Diabetes Specialist Nurse, St. Georges NHS Hospital Trust

16:21 - 16:26

Can diet and lifestyle education supported by continuous glucose monitoring replace the need for insulin in type 2 patients referred to group start sessions?

Isabelle Harrison, Dietitian, Newcastle upon Tyne Hospitals NHS Foundation Trust

16:27 - 16:32

The reliability of NEWS2 score and White Cell Count in assessing diabetic foot infection

Stephanie Tang, Senior podiatrist, King's College Hospital NHS Foundation Trust

16:33 - 16:38

Impact of neurodivergence on diabetes care and clinical outcomes: A Systematic Review

Thomas Johnston, Diabetes Specialist Nurse, Guy's & St Thomas

16:39 - 16:44

Rising Demand for Inpatient Palliative Care Among Adults with Diabetes in the UK: A 9-Year Retrospective Analysis (2017–2025)

Jason Cheung, Consultant Diabetologist, Norfolk and Norwich University Hospital NHS Foundation Trust

Diabetes UK Primary Care Award

Chairs:

Professor Samuel Seidu, Professor of Primary Care Diabetes and Cardiometabolic Medicine, University of Leicester

Nicola Milne, Practice Nurse, Northenden Group Practice

Speakers:

16:45 - 17.15

Progression from normal glucose handling to non-diabetic hypergycaemia – Development and Validation of an Incident Pre-diabetes Prediction Model

Aidan Ines, Chief Data Analyst, Nuffield Health Care

16:51 - 16:56

Managing diabetes mellitus in people with neuroendocrine tumours: pathophysiological insights and treatment approaches.

Muhammad Dr Associate Nizam, Associate Professor, SAPHO / Diabetes UK Aylesbury

16:57 - 17:02

Global guideline target achievements in glycaemic, blood pressure, and lipid control in type 2 diabetes: An updated meta-analysis of 1,618,972 participants

Ghanshyam Kacha, GP/Academic Clinical Fellow, University of Leicester

17:03 - 17:08

Changing pattern of GP referrals: experience from a community diabetes clinic

Jyoti Balani, Consultant Diabetologist, Epsom & St Helier NHS Trust

17:09 - 17:15

Discussion and closing remarks

This is a promotional sponsored symposium developed, organised, and funded by Lilly for UK Healthcare Professionals. Lilly products will be discussed. Lilly has provided a sponsorship towards this conference, however, have had no input, control, or influence over the agenda, speaker selections, presentations, or collateral content, except for this symposium session. Prescribing Information and Adverse Event reporting information will be available during the session.

CMAT-20107 April 2026

INTERACTIVE

Themes: Neurodiversity, social care

With the increasing recognition and diagnosis of neurodiversity and more and more young people and adults with learning difficulties being supported to live independently, how can the diabetes healthcare community ensure equity of access to care and good outcomes?

Laurence Taggart has been working with focus groups of people with learning difficulties and diabetes to discover what is important for them and will share that information with the conference, giving insights in what we can do now and in the future to model services to meet their needs. Alison Holloway has many years' experience of working with young people with diabetes (both type 1 and type 2) and who are neurodivergent and will explain how that can impact on their ability to manage their diabetes plus give practical tips on how best to support them.

16:15 - What adults with intellectual disability and their carers tell us about diabetes care in the UK.

Professor Laurence Taggart, Professor of Implementation Science, Queen's University Belfast

16:35 - Supporting neurodivergence in diabetes care: Clinical Implications, adaptations and practical strategies

Alison Holloway, Specialist Diabetes Dietitians, Sheffield Teaching Hospitals NHS Trust 

17.00 - Q&A

Thematic area: Narrative, person-centred

Theme: Psychology & wellbeing in diabetes care, diabetes lived experience

Specialism: Community care, Specialist care, Paediatrics and Primary care

An interactive session with young people from the Together Type 1 team, giving an insight on the challenges of managing diabetes as a young adult, along with examples of effective working relationships with HCP and suggestions for how things can be improved in the future.

16:15 - Why I want to share my lived experience, and the difference it makes

Calum Skye, Young Leader, Together Type 1 from Diabetes UK

16.25 Grounding education in real life - the SEREN Connect experience

Sara Crowley, Diabetes Translational Care National Coordinator, NHS Wales

16:35 - Recipes for engagement 

Anita Sehdev, Youth Voice Advisor, Royal College of Paediatrics and Child Health

16:45 - A people-first communications approach - how Together Type 1 amplifies the authentic voice of people living with type 1 diabetes

Jon Matthias, Communications Manager, Together Type 1 from Diabetes UK

16:55 - Discussion and practical workshop facilitated by Young Leaders representing Together Type 1 from Diabetes UK

16:15 - 16:20

Type 1 diabetes risk in UK adults in the general population

Kathleen Gillespie, Professor, University of Bristol

16:21 - 16:26

Lower incidence of type 1 diabetes incidence in South Asian and Black children compared to White children: findings from a UK population-based study

Katie Young, Research Fellow, University of Exeter

16:27 - 16:32

Isle of wight diabetes project- early onset type 2 diabetes. A clinical review of classification leading to 10% reclassification

Hamid Mani, Consultant, Isle of Wight NHS Trust

16:33 - 16:38

Partitioned Polygenic Scores Reveal Mechanistic Heterogeneity in shared T2D and Hypertension Risk

Zhanna Balkhiyarova, Research Fellow, University of Surrey

16:39 - 16:44

Role of physiological measurement of insulin resistance and beta cell function in response variation to oral glucose-lowering therapy: TriMaster trial analysis

Catherine Angwin, Research Fellow, University of ExeterDiabetes UK Primary Care Award

16:45 - 16:50

Isle of wight diabetes project; GLP-1 based therapies drive superior metabolic outcomes in early-onest type 2 diabetes

Jay Saha, Doctor, Queen Alexandra Hospital

16:51 - 16:56

Exploring barriers and facilitators to the initiation of insulin therapy in people with type 2 diabetes from ethnic minority populations

Priscilla Katapa, University of Leicester

16:57 - 17:02

Rare variant analyses reveal lipid and red cell pathways affecting HbA1c accuracy

Camila Armirola Ricaurte, Postdoctoral Research Associate, University of Exeter

17:03 - 17:08

Optimising pre-pregnancy health in women with previous gestational diabetes mellitus on the island of Ireland: A qualitative study

Catherine George, PhD Candidate, Royal College of Surgeons in Ireland

17:09 - 17:15

Discussion and closing remarks

16:15 - 16:30

Islet RGS2 is downregulated in human obesity and CRISPR-Cas9 knock-out renders MIN6 β-cells susceptible to apoptotic stressors

Jessica Starikova, Research Associate, King's College London

16:30 - 16:45

Alyteserin-2a improved glucose tolerance, insulin secretion and insulin sensitivity in mice with diet-induced obesity-diabetes

Opeolu Ojo, Lecturer, University of Wolverhampton

16:45 - 17:00

Identification and validation of novel pancreatic acinar cell populations in type 2 diabetes

Ahmad Al Mrabeh, MRC Career Development Fellow, University of Edinburgh

17:00 - 17:15

Tocotrienol-Rich Fraction Confers Histological Renoprotection in a Type 2 Diabetic Rat Model

Christina Yap, Associate Professor, Monash University Malaysia

This year, on 22 April, the international Earth Day also falls on the Opening Day of our Diabetes UK Professional Conference, in a world famous city that has also committed to become a Net Zero Carbon City by 2030.

Diabetes UK is one of the first diabetes organisations committed to the Delivering A Net Zero NHS strategy and The Greener NHS initiatives, supporting the joint development of positional statement on Diabetes Care Sustainability, which will be launched by the authors and speakers on Day 2 of our conference.

We have set aside this one-hour space in our Networking Area, for colleagues and researchers alike who care about sustainable healthcare, including diabetes, to gather, connect, and share ideas, questions, and possible actions on this very important topic - for us and future generations.

Themes: Policy, quality improvement

- State of the Diabetes Nation from pre conception to the elderly frail population.

- Compare service delivery across the UK discussing variation of care delivery from primary care, paediatrics, young adults and secondary care services.

- Review the increase burden of meeting all care processes and providing access to technology and newer agents.

Themes: Complications, obesity, weight management, metabolic health

- Reviewing the latest evidence for weight loss surgery

- The role of weight loss surgery in diabetes care

- Debating the most effective treatments for diabetes and weight management

- The role of the bariatric surgeon in the diabetes MDT team

17:25 - Chairs opening remarks: 

Professor Ahmad Moolla, Honorary Consultant Physician, Royal Free NHS

17:27 - A summary of the latest evidence for bariatric surgery in people living with diabetes and how to present findings to patients

Professor Jane Blazeby, Professor of Surgery, University of Bristol and Honorary Consultant Surgeon, University Hospitals NHS Foundation Trust

17:41 - What is the evolving role of the bariatric surgeon and weight loss surgery as part of future multidisciplinary team services for diabetes care?

Professor Ahmed Ahmed, Consultant Surgeon and Clinical Professor in Metabolic Surgery, Imperial College Healthcare NHS Trust

17:55 - Why early large scale weight loss may be the future of diabetes care

Professor Naveed Sattar, Professor of Cardiometabolic Medicine & Honorary Consultant Physician, University of Glasgow

18:09 - Discussion and Q&A

Judges:

- Dr Parizad Avari

- Dr Alexandros Liarakos

- Dr Aaisha Saqib

17:25 - 17:40

Quantifying Diabetes Stigma in the Inpatient Setting: A Service Evaluation Using SSCI-8

Thazin Wynn, Specialist Registrar, Norfolk & Norwich University Hospital

17:40 - 17:55

The Impact of Blood Pressure Variability and African-Caribbean ethnicity on the Progression of Diabetic Kidney Disease in Type 1 Diabetes

Murat Ozdede, Research Fellow, King's College London

17:55 - 18:10

Evaluating the Impact of Continuous Subcutaneous Insulin Infusion (CSII) on Retinopathy in people with Type 1 Diabetes within the first year of CSII initiation

Xi Tang Wen, Academic Clinical Fellow/IMT2, Norfolk and Norwich University Hospital

18:10 - 18:25

Discussion and closing remarks

The session will cover the most recent new evidence on how the brain controls food intake and energy expenditure.

Themes: Inequalities, community engagement, service design, primary care

17.25 - Sensory regulation of metabolism

Sophie Steculorum, Prinicpal Invesitgator, Max Planck Institute for Metabolism Research

17.45 - New Insights into the Brain Control of Appetite and Obesity

Professor Lora Heisler, Professor of Human Nutrition, University of Aberdeen

18.05 - Sympathetic Neurobiology in Obesity

Professor Ana Domingos, Professor of Neuroscience, University of Oxford

INTERACTIVE

Themes: Clinical care & diagnosis, health inequalities, psychosocial impact

Specialisms: Clinical science, Community care, Specialist care, Paediatrics and Primary care

This workshop will cover the practical aspects of diabetes classification with an overview of the EASD/ADA consensus pathway for classification. It will showcase data from a novel prospective study of diabetes classification and include case based discussion on unusual presentations across different age groups, ethnicities and aetiologies.

17:25 - Chair's introduction

17:30 - Classifying diabetes at diagnosis, case discussions and insights from the StartRight prospective study

Professor Angus Jones, University of Exeter and Honorary Consultant Physician, Royal Devon University Healthcare NHS Foundation Trust

17:45 - Case studies to highlight the impact of ethnicity on classification

Dr Shivani Misra, Consultant Physician, Associate Professor and Head of Section Metabolic Medicine Imperial College London

18:00 - The EASD-ADA Management of type 1 diabetes in adults consensus report: differentiating type 1 diabetes from type 2 diabetes or monogenic diabetes

Richard Holt, Professor in diabetes and endocrinology, Faculty of Medicine, University of Southampton

17:25 - 17:40

The Diabetic Body: Young Women’s Experiences of Diabetes, Identity, and Body Image

Katie Lamb, Coventry University

17:40 - 17:55

SHIFT: Using conversation cards to build equity awareness in diabetes and pregnancy care

Jade Deacon Cummings, Midwife, Guy’s and St Thomas Hospital NHS Trust

17:55 - 18:10

Real-world Outcomes of Tirzepatide Use in a Diabetes Weight Management Clinic: A Retrospective Observational Study

Raghavendar Palani, ST7, University Hospital Birmingham

18:10 - 18:25

Assessing Resident Doctors' confidence and knowledge in insulin and prescriptions using paper drug charts

Henna Gill, FY2, University Hospitals Sussex

17:25 - 17:40

Physical function in people living with Type 1 Diabetes

Sahar Khodabakhsh, Trial and Project Manager, Leicester Diabetes Centre

17:40 - 17:55

Functional data analysis of postprandial glucose responses to mixed-meals identifies latent phenotypes in Type 1 diabetes with divergent vascular risk profiles

Will Evans, Senior Lecturer Exercise Physiology, University of Sunderland

17:55 - 18:10

High-intensity interval training alters immune response to hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemia

Catriona Farrell, Clinical Senior Lecturer, University of Dundee

18:10 - 18:25

Experience and acceptability of a reduced-energy whole diet intervention in women with gestational diabetes; A qualitative study of the DiGest trial

Laura Kusinski, Post-doctoral research associate, University of Leicester